Home
About
Publications Trends
Recent Publications
Expert Search
Archive
sunitinib
What Types of Cancer is Sunitinib Used For?
Sunitinib is approved for the treatment of several types of cancer, including:
Renal Cell Carcinoma (RCC)
: Sunitinib is commonly used as a first-line treatment for advanced RCC.
Gastrointestinal Stromal Tumor (GIST)
: It is used when the tumor is unresectable or has metastasized and is resistant to imatinib.
Pancreatic Neuroendocrine Tumors (pNET)
: Sunitinib is indicated for the treatment of progressive, well-differentiated pNETs.
Frequently asked queries:
What is Sunitinib?
How Does Sunitinib Work?
What Types of Cancer is Sunitinib Used For?
How is Sunitinib Administered?
How Often Should MLD be Performed?
What is DNA Profiling?
What is Allergic Bronchopulmonary Aspergillosis (ABPA)?
What Role Does Insulin Play?
How Are Cloud Services Supporting Precision Medicine in Cancer Treatment?
What is mRNA Expression?
How is Temozolomide administered?
Can High Field MRI Differentiate Between Benign and Malignant Tumors?
What Are the Limitations of Genetic Testing?
Can Lifestyle Changes Reduce Side Effects?
Are There Preventive Measures for Poor Circulation in Cancer Patients?
What is the Prognosis for Patients with Nonsense Mutations in Cancer?
How Can Nutrition and Physical Activity Improve Quality of Life?
How are the Findings of Cancer Audits Used?
What are Some Examples of Cancer Biomarkers?
Which Whole Foods are Most Beneficial?
Top Searches
Brain Tumor
Breast cancer
cancer
Cancer Genomics
Chemotherapy
hepatocellular carcinoma
Lung Cancer
Nanotechnology
Non-Hodgkin’s Lymphoma
Radiation-Induced Malignancies
Follow Us
Facebook
Linkedin
Youtube
Instagram
Partnered Content Networks
Relevant Topics
4D Segmentation
Alopecia
Atlas-based Segmentation
Automated Segmentation
B-cell malignancies
biomarkers
Brain Tumor
Brain Tumor Segmentation
Breast cancer
cancer
Cancer Genome Atlas
Cancer genomics
Cancer treatment
CAR T-cell therapy
Carcinogenesis
cell adhesion
cell migration
chemotherapy
Chromatin remodeling genes
Chronic inflammation
CIAbimatoprost
Co-morbidity
Combination therapy
Copy number variations
cytokine release syndrome
Deep Learning
Diagnosis challenges
diffuse large B-cell lymphoma
DNA damage
docetaxel-cyclophosphamide
Drug delivery
epirubicin-cyclophosphamide
extracellular matrix
Fibrosis
Genetic alteration
Glioblastoma
Gold nanoparticles
Hepatocellular carcinoma
High Tumor
image-guided radiotherapy
Imaging Techniques
Immunosuppression
Immunotherapy
Integrative genomics
integrin inhibitors
Integrins
intensity-modulated radiation therapy
Keratinocyte
Lipid-based nanoparticles
liver cancer
long-term cancer risks
Lung cancer
Machine Learning
Magnetic Resonance Imaging
metastasis
methyltransferase
MRI
Multi-modal Imaging
Multidisciplinary care
Mutual exclusivity analysis
Nanoparticles
Nanotechnology
neoadjuvant radiotherapy
neurotoxicity
Next-generation sequencing
nnovative Biomarkers
Non-Hodgkin’s lymphoma
Novel Biomarkers for Brain Tumors
Novel Chemotherapy
Oncogenic transcription factors
oncological diseases
paclitaxel
Personalized medicine
Photobiomodulation therapy
Polymeric nanoparticles
portal vein tumor thrombus
Probabilistic Models
proton therapy
Radiation-induced malignancies
radiotherapy
refractory lymphoma
relapsed lymphoma
Risk factors
secondary cancer prevention
secondary cancers
Silver nanoparticles
stereotactic body radiation therapy
Targeted therapy
Tolerability
transarterial chemoembolization
Tuberculosis
tumor microenvironment
tumor progression
Voltage-gated sodium channels
Subscribe to our Newsletter
Stay updated with our latest news and offers related to Cancer.
Subscribe